These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2424622)

  • 1. Cytostatic activity of in vitro generated macrophages: evidence for a prostaglandin-independent reversible cytostatic mechanism.
    Stout RD
    Cell Immunol; 1985 Nov; 96(1):83-103. PubMed ID: 2424622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated inhibition of proliferation and activation of alloreactive cytotoxic lymphocytes: maintenance of response potential of precursors and dissociation between proliferation and effector function of activated cytotoxic lymphocytes.
    Stout RD; Suttles J; Persiani DM; Bakke O
    Cell Immunol; 1986 Aug; 101(1):105-21. PubMed ID: 2943413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Corynebacterium parvum in the activation of peritoneal macrophages. II. Identification of distinguishable anti-tumor activities by macrophage subpopulations.
    Chapes SK; Haskill S
    Cell Immunol; 1983 Feb; 76(1):49-57. PubMed ID: 6219754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene D4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumour cells.
    Ophir R; Ben-Efraim S; Bonta IL
    Int J Tissue React; 1987; 9(3):189-94. PubMed ID: 3596960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characteristics of in vitro generated macrophages: a transient refractory state precedes reinducibility of a spatially restricted, possibly contact-dependent, cytostatic mechanism.
    Stout RD; Suttles J
    Cell Immunol; 1987 Mar; 105(1):33-44. PubMed ID: 3493083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages.
    Decker T; Lohmann-Matthes ML; Karck U; Peters T; Decker K
    J Leukoc Biol; 1989 Feb; 45(2):139-46. PubMed ID: 2783725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of lymphocyte proliferative responses: demonstration of two stages occurring in the in vitro generation of suppressor macrophages.
    Stout RD; Fisher M
    J Immunol; 1983 Apr; 130(4):1580-5. PubMed ID: 6833748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory macrophage response to murine cytomegalovirus in genetically susceptible mice.
    Price P; Winter JG; Shellam GR
    Arch Virol; 1989; 106(1-2):35-50. PubMed ID: 2548459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic macrophage function in early syphilitic infection is complex. Stimulation versus down-regulation.
    Tomai MA; Fitzgerald TJ
    J Immunol; 1991 May; 146(9):3171-6. PubMed ID: 1901894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host response to myeloma: effect of syngeneic spleen cells on the growth and function of MOPC 104E myeloma in vitro.
    Miura T; Ghanta VK; Hiramoto RN
    Cancer Invest; 1990; 8(1):17-25. PubMed ID: 2350718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of target cell mitosis as a measure of the cytostatic effects of activated macrophages on tumor target cells.
    Krahenbuhl JL; Remington JS
    Cancer Res; 1977 Nov; 37(11):3912-6. PubMed ID: 908031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of metastatic versus nonmetastatic mammary tumor cells to macrophage-mediated cytostasis.
    Yamashina K; Fulton A; Heppner G
    J Natl Cancer Inst; 1985 Oct; 75(4):765-70. PubMed ID: 3862907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene).
    Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
    Cancer Res; 1984 Jun; 44(6):2363-7. PubMed ID: 6426780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of macrophage activity by 12-O-tetradecanoylphorbol-13-acetate.
    Gemsa D; Staar U; Grimm W; Hausmann G; Körner CF; Resch K; Krammer PH
    IARC Sci Publ; 1984; (56):319-36. PubMed ID: 6085623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of lymphocyte proliferative responses: characterization of the suppressor and kinetics of suppression.
    Stout RD; Fisher M
    J Immunol; 1983 Apr; 130(4):1573-9. PubMed ID: 6220059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interaction of a cytokine produced by embryonic fibroblasts and a lymphokine contained in Con A-stimulated spleen cell culture for murine macrophage differentiation: a model experiment using cell line cells, M1.
    Noro N; Kyoizumi S; Yodoi J; Masuda T
    Cell Immunol; 1985 Oct; 95(1):124-36. PubMed ID: 2411431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide and splenic tumoricidal macrophage activation.
    Verstovsek S; Zaleskis G; Maccubbin DL; Mihich E; Ehrke MJ
    J Leukoc Biol; 1994 Dec; 56(6):714-22. PubMed ID: 7996047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bacterial lipopolysaccharide on protein synthesis in murine peritoneal macrophages: relationship to activation for macrophage tumoricidal function.
    Hamilton TA; Jansen MM; Somers SD; Adams DO
    J Cell Physiol; 1986 Jul; 128(1):9-17. PubMed ID: 3087999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.
    Sugawara I; Lee KC; Wong M
    Cancer Immunol Immunother; 1984; 16(3):137-44. PubMed ID: 6322974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.